You are viewing a free preview of this lesson.
Subscribe to unlock all 10 lessons in this course and every other course on LearningBro.
Antibiotics are among the most important medical discoveries in history, but their effectiveness is being threatened by the rise of antimicrobial resistance (AMR). This lesson covers the mechanisms of antibiotic action, how resistance develops and spreads, and strategies to combat AMR, as required by the Edexcel A-Level Biology (9BI0) specification.
Antibiotics are chemicals produced by microorganisms (or synthesised artificially) that kill or inhibit the growth of bacteria without significantly harming human cells.
| Term | Definition |
|---|---|
| Bactericidal | An antibiotic that kills bacteria |
| Bacteriostatic | An antibiotic that inhibits the growth of bacteria (stops them reproducing) without killing them |
| Broad-spectrum | Effective against a wide range of bacteria (both Gram-positive and Gram-negative) |
| Narrow-spectrum | Effective against only a specific group of bacteria |
Exam Tip: Antibiotics are effective against bacteria only. They do not work against viruses (which lack the cellular structures that antibiotics target). This is a very commonly examined point.
Antibiotics target specific bacterial structures or processes that are either absent from or significantly different in human cells.
| Target | Antibiotic | Mechanism | Type |
|---|---|---|---|
| Cell wall synthesis | Penicillin, amoxicillin, methicillin | Inhibits transpeptidase (the enzyme that cross-links peptidoglycan chains), weakening the cell wall. The bacterium cannot withstand osmotic pressure and lyses. | Bactericidal |
| Protein synthesis (30S ribosome) | Tetracycline | Binds to the 30S subunit of the bacterial ribosome, preventing tRNA binding and blocking translation | Bacteriostatic |
| Protein synthesis (50S ribosome) | Erythromycin, chloramphenicol | Binds to the 50S subunit of the bacterial ribosome, blocking peptide bond formation | Bacteriostatic / Bactericidal |
| DNA replication | Ciprofloxacin (fluoroquinolone) | Inhibits DNA gyrase (topoisomerase II), preventing DNA replication | Bactericidal |
| RNA synthesis | Rifampicin | Inhibits RNA polymerase, preventing transcription | Bactericidal |
| Folate synthesis | Trimethoprim, sulfamethoxazole | Inhibits enzymes in the folic acid synthesis pathway (which bacteria require but humans obtain from diet) | Bacteriostatic |
| Cell membrane integrity | Polymyxins | Disrupts the bacterial cell membrane, causing leakage of cell contents | Bactericidal |
Exam Tip: Penicillin works by preventing the cross-linking of peptidoglycan in the bacterial cell wall. Bacteria that are actively dividing are most susceptible because they are synthesising new cell wall material. Penicillin is bactericidal because without a functional cell wall, the bacterium lyses due to osmotic influx of water.
Antimicrobial resistance occurs when microorganisms (especially bacteria) evolve mechanisms to survive exposure to antibiotics that would normally kill or inhibit them.
| Mechanism | How it works | Example |
|---|---|---|
| Enzyme modification/destruction of antibiotic | Bacteria produce enzymes that break down or chemically modify the antibiotic | β-lactamase (penicillinase) breaks the β-lactam ring in penicillin, rendering it inactive |
| Altered target site | The target molecule is modified so the antibiotic can no longer bind | MRSA has a modified transpeptidase (PBP2a) that penicillin cannot bind to |
| Efflux pumps | Membrane proteins actively pump the antibiotic out of the cell before it can act | Tetracycline resistance; some multi-drug resistance |
| Reduced permeability | Changes in the outer membrane reduce antibiotic uptake | Gram-negative bacteria may lose porins, preventing antibiotic entry |
| Bypass pathways | The bacterium develops an alternative metabolic pathway that bypasses the antibiotic's target | Vancomycin-resistant enterococci (VRE) modify cell wall precursors |
Resistance arises through natural selection — it is an evolutionary process, not something the individual bacterium "learns".
The following diagram illustrates how antibiotic resistance develops through natural selection:
flowchart TD
A["Bacterial Population<br/>(most susceptible)"] --> B["Antibiotic Applied"]
B --> C["Susceptible Bacteria<br/>Killed"]
B --> D["Resistant Mutant<br/>Survives"]
D --> E["Reproduces<br/>(no competition)"]
E --> F["Population Now<br/>Mostly Resistant"]
F -->|"Horizontal Gene<br/>Transfer"| G["Resistance Spreads<br/>to Other Species"]
Resistance genes can also spread between bacteria (even between different species) through horizontal gene transfer:
| Method | Description |
|---|---|
| Conjugation | Direct transfer of a plasmid (carrying resistance genes) from one bacterium to another via a pilus |
| Transformation | Uptake of free DNA fragments (from dead bacteria) from the environment |
| Transduction | Transfer of DNA between bacteria by a bacteriophage (virus that infects bacteria) |
Exam Tip: The antibiotic does NOT cause the mutation. The mutation arises randomly before exposure. The antibiotic acts as a selection pressure, selecting for the resistant individuals. This is a key distinction — examiners test whether you understand this aspect of natural selection.
MRSA (Methicillin-Resistant Staphylococcus aureus) is one of the best-known examples of antibiotic resistance.
| Feature | Detail |
|---|---|
| Organism | Staphylococcus aureus (Gram-positive coccus) |
| Resistance gene | mecA gene (carried on a mobile genetic element) |
| Mechanism | Codes for PBP2a, a modified transpeptidase that penicillin and methicillin cannot bind to |
| Diseases caused | Skin infections, wound infections, septicaemia, pneumonia |
| Treatment | Vancomycin, linezolid (antibiotics of last resort) |
| Concern | Some strains are now showing vancomycin resistance (VRSA), leaving almost no treatment options |
| Factor | Explanation |
|---|---|
| Over-prescription of antibiotics | Antibiotics prescribed when not needed (e.g. for viral infections) increases selection pressure |
| Incomplete courses | Patients stopping antibiotics early may leave resistant bacteria alive |
| Use in agriculture | Antibiotics used as growth promoters or prophylactics in livestock select for resistant bacteria that can transfer to humans via the food chain |
| Poor infection control | Inadequate hygiene in hospitals allows resistant bacteria (e.g. MRSA) to spread |
| Global travel | Resistant bacteria can spread internationally via travellers |
| Lack of new antibiotics | Few new antibiotic classes have been developed in recent decades |
| Strategy | How it helps |
|---|---|
| Antibiotic stewardship | Prescribe antibiotics only when necessary; use narrow-spectrum antibiotics where possible; complete the full course |
| Infection prevention | Hand hygiene, hospital cleaning protocols, isolation of infected patients |
| Vaccination | Preventing infection reduces the need for antibiotics |
| Agricultural regulation | Banning or reducing the use of antibiotics in animal farming |
| Research and development | Developing new antibiotics, alternative therapies (e.g. bacteriophage therapy, antimicrobial peptides) |
| Surveillance | Monitoring resistance patterns nationally and globally (e.g. by Public Health England, WHO) |
| Public education | Teaching patients not to demand antibiotics for viral infections; emphasising the importance of completing courses |
Exam Tip: Questions on AMR frequently require you to apply knowledge of natural selection. Use the correct terminology: mutation, variation, selection pressure, survival of resistant individuals, reproduction, and increase in allele frequency.
This practical technique is used to determine which antibiotics are effective against a specific bacterial strain:
| Term | Definition |
|---|---|
| Antibiotic | A substance that kills or inhibits the growth of bacteria |
| Antimicrobial resistance (AMR) | The ability of microorganisms to survive exposure to antimicrobial agents that would normally kill or inhibit them |
| MRSA | Methicillin-resistant Staphylococcus aureus; a bacterium resistant to multiple antibiotics |
| β-lactamase | An enzyme produced by resistant bacteria that breaks down β-lactam antibiotics (e.g. penicillin) |
| Horizontal gene transfer | The transfer of genetic material between bacteria by conjugation, transformation, or transduction |
| Selection pressure | An environmental factor (e.g. antibiotic exposure) that favours individuals with certain traits |
| Antibiotic stewardship | Strategies to ensure antibiotics are prescribed and used responsibly |
The Edexcel 9BI0 specification places antibiotics and antimicrobial resistance at the end of Topic 6: Immunity, Infection and Forensics as the public-health capstone of the microbiology and immunology sequence. Lesson 1 (microorganisms) supplies the structural rationale for selective toxicity — peptidoglycan cell walls and 70S ribosomes are uniquely prokaryotic and therefore druggable without harming the eukaryotic host. Lesson 2 (bacterial growth) supplies the kinetic context — most antibiotics, particularly cell-wall-active β-lactams, are most active against bacteria in log (exponential) phase when peptidoglycan is being actively synthesised; persister cells in lag or stationary phase tolerate exposure. Lessons 6 and 7 (innate and adaptive immunity) clarify that antibiotics rarely act alone — bacteriostatic agents inhibit growth and let phagocytes and antibody-coated complement finish the job. Lesson 9 (vaccination) is the alternative containment strategy: every prevented infection is an antibiotic course not given, slowing the rise of resistance. Synoptic links extend to Topic 8 (gene technology), where plasmid-borne resistance genes spread via horizontal gene transfer and where PCR and whole-genome sequencing are now used to detect resistance determinants directly. Relevant statements concern the action of antibiotics on prokaryotic targets, the development of resistance through natural selection, and the strategies for stewardship (refer to the official Pearson Edexcel 9BI0 specification document for exact wording).
Question (8 marks):
A patient presents with a urinary-tract infection caused by Escherichia coli. Initial empirical treatment with amoxicillin fails. Laboratory testing reveals the strain produces an extended-spectrum β-lactamase (ESBL) and the gene is located on a transmissible plasmid.
(a) Explain how amoxicillin (a β-lactam antibiotic) normally kills susceptible E. coli, including why it does not significantly harm the patient's own cells. (4)
(b) Explain why this strain is resistant to amoxicillin but might still respond to co-amoxiclav (amoxicillin combined with clavulanic acid), and describe how the resistance gene could spread to other bacterial species in the gut. (4)
Solution with mark scheme:
(a) M1 (AO1.1) — Amoxicillin is a β-lactam antibiotic whose β-lactam ring is a structural mimic of the D-Ala-D-Ala terminus of the peptidoglycan precursor. It binds and irreversibly acylates transpeptidase enzymes (also called penicillin-binding proteins, PBPs) that catalyse the crosslinking of peptide side chains between adjacent glycan strands.
M1 (AO1.2) — With crosslinking inhibited, newly synthesised peptidoglycan cannot be reinforced. Because E. coli continues to grow and the existing wall is continuously remodelled by autolysins, the wall weakens.
A1 (AO2.1) — Bacteria are hypertonic relative to the surrounding medium; without a load-bearing peptidoglycan layer the cell lyses osmotically as water enters by osmosis. The action is therefore bactericidal during active growth (log phase).
A1 (AO3.1a) — Selective toxicity arises because animal cells lack peptidoglycan and lack PBPs — there is no human equivalent target. The drug therefore exhibits a wide therapeutic window despite being highly chemically reactive.
(b) M1 (AO1.2) — The ESBL strain produces a β-lactamase enzyme that hydrolyses the β-lactam ring of amoxicillin before it can reach the PBPs. The drug is inactivated extracellularly (Gram-negative periplasm), so transpeptidase activity is preserved and the cell wall is not disrupted.
M1 (AO2.1) — Co-amoxiclav combines amoxicillin with clavulanic acid, a suicide inhibitor that binds the β-lactamase active site irreversibly. With the resistance enzyme blocked, the amoxicillin reaches its PBP target intact, and crosslinking inhibition resumes. Co-amoxiclav can therefore overcome simple β-lactamase-mediated resistance, though many ESBL enzymes have evolved partial resistance to clavulanic acid itself.
A1 (AO1.2) — The plasmid carrying the ESBL gene can spread by horizontal gene transfer. The dominant mechanism in Gram-negative gut flora is conjugation: a sex pilus encoded by the plasmid forms a cytoplasmic bridge between donor and recipient, the plasmid is nicked, single-stranded DNA is transferred, and complementary strand synthesis re-circularises the plasmid in the recipient.
A1 (AO3.1a) — Other routes are transformation (uptake of free plasmid DNA from lysed cells) and transduction (bacteriophage-mediated transfer). Because conjugative plasmids cross species boundaries within the Enterobacteriaceae, an ESBL gene in E. coli can transfer to Klebsiella pneumoniae in hours under selective pressure — far faster than chromosomal mutation.
Total: 8 marks.
Question (6 marks): Explain how bacterial populations evolve resistance to antibiotics, with reference to mutation, selection pressure and horizontal gene transfer. Use a named example to illustrate the clinical significance.
Mark scheme decomposition by AO:
| Marking point | AO | Credit-worthy content |
|---|---|---|
| 1 | AO1.1 | States that bacterial populations show genetic variation generated by spontaneous mutation during DNA replication; large population sizes (109 cells per mL of culture) and short generation times (~20 min for E. coli) make rare mutations almost inevitable. |
| 2 | AO1.2 | Describes selection pressure imposed by antibiotic exposure: susceptible cells are killed or inhibited; rare cells carrying a resistance allele (altered target, efflux pump, degrading enzyme) survive and reproduce, increasing the allele frequency in the next generation — directional natural selection. |
| 3 | AO2.1 | Distinguishes vertical transmission (binary fission, mother-to-daughter) from horizontal gene transfer. Names the three HGT routes: conjugation (plasmid transfer via sex pilus), transformation (uptake of naked DNA), transduction (phage-mediated). Plasmids often carry multiple resistance genes in cassettes, so one transfer event confers multidrug resistance. |
| 4 | AO2.1 | Explains why HGT is far faster than chromosomal mutation: a single conjugation event delivers the resistance allele in a fully functional plasmid to a naive recipient in minutes; chromosomal mutations require many generations to reach fixation by selection alone. |
| 5 | AO3.1a | Worked example: MRSA (methicillin-resistant Staphylococcus aureus) carries the mecA gene encoding PBP2a, a transpeptidase with low affinity for β-lactams. The gene resides on a chromosomal mobile element (SCCmec) acquired by horizontal transfer. Hospital antibiotic use selects for MRSA, which now causes a substantial fraction of healthcare-associated bloodstream infections. |
| 6 | AO3.2a | Concludes that AMR is inevitable wherever antibiotics are used — the question is the rate, not the existence. Stewardship slows the rise; vaccination prevents the infections that would otherwise need antibiotics; new-drug pipelines must run faster than resistance emergence. |
Total: 6 marks (AO1 = 2, AO2 = 2, AO3 = 2). Specimen question modelled on the Edexcel 9BI0 paper format.
Subscribe to continue reading
Get full access to this lesson and all 10 lessons in this course.